AMLODIPINE AND ATORVASTATIN

Generic: AMLODIPINE AND ATORVASTATIN

Alembic Pharmaceuticals Inc.Manufacturer
ORALRoute
AMLODIPINE BESYLATEActive Substance
2025-05-22Original Approval

AMLODIPINE AND ATORVASTATIN is FDA application ANDA217279, sponsored by ALEMBIC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
FATIGUE
37 reports
2
DIARRHOEA
31 reports
3
DEATH
27 reports
4
DYSPNOEA
24 reports
5
COUGH
23 reports
6
DIZZINESS
20 reports
7
PNEUMONIA
20 reports
8
HEADACHE
18 reports
9
NAUSEA
18 reports
10
ASTHENIA
17 reports